BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, May 10, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2003
View Archived Issues
Adenylate cyclase activators discovered at Nippon Kayaku
Read More
Merck designs new factor Xa and/or factor VIIa inhibitors
Read More
Novel anti-H. pylori agents that act by inhibiting MurI glutamate racemase
Read More
Lundbeck describes novel 5-HT1A ligands with 5-HT reuptake/dopamine receptor activity
Read More
GSK researchers discover new DPP inhibitors
Read More
Purine-based CDK inhibitors newly identified at Cyclacel
Read More
New PDE5 inhibitors in early development at Tanabe Seiyaku
Read More
Sunesis and Merck & Co. form Alzheimer's research collaboration
Read More
DakoCytomation obtains license for cancer diagnostic antibody
Read More
PhotoCure submits NDA for Metvix to FDA
Read More
Approvable letter issued for Zelapar
Read More
Eligard 30 mg receives FDA approval
Read More
Encouraging results obtained for Exanta in prevention of stroke in atrial fibrillation
Read More
Theseus Imaging enters clinical trial agreement with NCI for Hynic-Annexin V
Read More
U.S. centers cleared to join Pharmos's phase III trial of dexanabinol
Read More
Valentis updates progress of phase I del-1 trial
Read More
Phase III trial results announced for Riquent
Read More
HuMax-CD20 kills rituximab-resistant tumor cells in preclinical studies
Read More
New preclinical data reported for HuMax-EGFr
Read More
Canadian approval for Xigris
Read More
Potentially favorable pharmacokinetic and safety profile confirmed for UK-427857
Read More
A potential new target for HIV drugs: LEDGF/p75
Read More
Pyranodipyrimidine HIV integrase inhibitors with a novel mode of action
Read More
Atypical retinoid exerts potent antiproliferative and proapoptotic effects
Read More
Broadly crossreactive HIV-neutralizing antibodies available for licensing from NIH
Read More
Antidepressant- and anxiolytic-like effects for MCL-0129, a new MC4 receptor antagonist
Read More